Go to
JCI Insight
Citations to this article
Lamis Yehia, … , Joanne Ngeow, Charis Eng
Published January 7, 2019
Citation Information: J Clin Invest. 2019;129(2):452-464. https://doi.org/10.1172/JCI121277.
Citation Information: J Clin Invest. 2019;129(2):452-464. https://doi.org/10.1172/JCI121277.
Abstract
The tumor suppressor phosphatase and tensin homolog (PTEN) classically counteracts the PI3K/AKT/mTOR signaling cascade. Germline pathogenic PTEN mutations cause PTEN hamartoma tumor syndrome (PHTS), featuring various benign and malignant tumors, as well as neurodevelopmental disorders such as autism spectrum disorder. Germline and somatic mosaic mutations in genes encoding components of the PI3K/AKT/mTOR pathway downstream of PTEN predispose to syndromes with partially overlapping clinical features, termed the “PTEN-opathies.” Experimental models of PTEN pathway disruption uncover the molecular and cellular processes influencing clinical phenotypic manifestations. Such insights not only teach us about biological mechanisms in states of health and disease, but also enable more accurate gene-informed cancer risk assessment, medical management, and targeted therapeutics. Hence, the PTEN-opathies serve as a prototype for bedside to bench, and back to the bedside, practice of evidence-based precision medicine.
Authors
Lamis Yehia, Joanne Ngeow, Charis Eng
Total citations by year
Citation information
Citations to this article (104)
| Title and authors | Publication | Year |
|---|---|---|
|
Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis Complex
Schultz KA, MacFarland SP, Perrino MR, Mitchell SG, Kamihara J, Nelson AT, Mallinger PH, Brzezinski JJ, Maxwell KN, Woodward ER, Gallinger B, Kim SY, Greer ML, Schneider KW, Scollon SR, Das A, Wasserman JD, Eng C, Malkin D, Foulkes WD, Michaeli O, Bauer AJ, Stewart DR |
Clinical cancer research : an official journal of the American Association for Cancer Research | 2025 |
|
Cowden Syndrome and Oral Lesions: A Case Report Using MLPA
Barrón-Márquez MC, González-González R, Bobadilla-Morales L, Rodriguez-Machuca VU, Bologna-Molina R, Molina-Frechero N, Tremillo-Maldonado OA, López-Verdín S |
The American Journal of Case Reports | 2025 |
|
PTEN-mediated resistance in cancer: From foundation to future therapies
Tufail M |
Toxicology Reports | 2025 |
|
Clinical-Genetic Approach to Conditions with Macrocephaly and ASD/Behaviour Abnormalities: Variants in PTEN and PPP2R5D Are the Most Recurrent Gene Mutations in a Patient-Oriented Diagnostic Strategy
L\u2019Erario FF, Gazzellone A, Contaldo I, Veredice C, Carapelle M, Renzi AG, Modafferi C, Palucci M, D\u2019Ambrosio P, Sonnini E, Loberti L, Panfili A, Lucci Cordisco E, Chiurazzi P, Trevisan V, Leoni C, Zampino G, Pomponi MG, Orteschi D, Zollino M, Marangi G |
Genes | 2025 |
|
Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working Group
Dhawan A, Baitamouni S, Liu D, Yehia L, Anthony K, McCarther A, Tischkowitz M, MacFarland SP, Ngeow J, Hoogerbrugge N, Eng C |
Clinical Cancer Research | 2025 |
|
Therapeutic Potential of Translational Readthrough at Disease‐Associated Premature Termination Codons From Tumor Suppressor Genes
Torices L, Nunes\u2010Xavier CE, Pulido R |
Iubmb Life | 2025 |
|
Germline Variants in Pediatric Cancer : Based on Oncogenic Pathways.
Kim JW |
Journal of Korean Neurosurgical Society | 2025 |
|
Genomic diversity in functionally relevant genes modifies neurodevelopmental versus neoplastic risks in individuals with germline PTEN variants.
Kim AY, Yehia L, Eng C |
NPJ genomic medicine | 2025 |
|
A De Novo PTEN Pathogenic Variant in a Young Girl with Sporadic Cowden Syndrome—A Case Report
Gebhart P, Singer C, Muhr D, Stein C, Tan YY |
Pediatric Reports | 2025 |
|
mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node
Mantoan Ritter L, Annear NM, Baple EL, Ben-Chaabane LY, Bodi I, Brosson L, Cadwgan JE, Coslett B, Crosby AH, Davies DM, Daykin N, Dedeurwaerdere S, Dühring Fenger C, Dunlop EA, Elmslie FV, Girodengo M, Hambleton S, Jansen AC, Johnson SR, Kearley KC, Kingswood JC, Laaniste L, Lachlan K, Latchford A, Madsen RR, Mansour S, Mihaylov SR, Muhammed L, Oliver C, Pepper T, Rawlins LE, Schim van der Loeff I, Siddiqui A, Takhar P, Tatton-Brown K, Tee AR, Tibarewal P, Tye C, Ultanir SK, Vanhaesebroeck B, Zare B, Pal DK, Bateman JM |
Orphanet Journal of Rare Diseases | 2025 |
|
PTEN Deregulation Mechanisms in Salivary Gland Carcinomas
PAPANIKOLAOU V, CHRYSOVERGIS A, ADAMOPOULOU M, SPYROPOULOU D, ROUKAS D, PAPANASTASIOU G, MASTRONIKOLI S, PAPOULIAKOS S, MANAIOS L, TSIAMBAS E, PANTOS P, RAGOS V, FOTIADES P, PESCHOS D, MASTRONIKOLIS N, KYRODIMOS E |
2024 | |
|
Multiple bronchial carcinoids associated with Cowden syndrome.
Tömböl Z, Tőke J, Tóth G, Varga Z, Balázs E, Tóth E, Gergely L, Danihel Ľ, Medvecz M, Borka K, Tóth M |
Endocrine | 2024 |
|
Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with PTEN hamartoma tumor syndrome
Liu D, Yehia L, Dhawan A, Ni Y, Eng C |
Cell reports. Medicine | 2024 |
|
Atrophic changes in thyroid tumors are strong indicators of underlying DICER1 mutations: a bi-institutional genotype-phenotype correlation study.
Condello V, Roberts JW, Stenman A, Larsson C, Viswanathan K, Juhlin CC |
Virchows Archiv : an international journal of pathology | 2024 |
|
Insights into Clinical Disorders in Cowden Syndrome: A Comprehensive Review
Pîrlog LM, Pătrășcanu AA, Militaru MS, Cătană A |
Medicina | 2024 |
|
Establishment of Novel High-Grade Serous Ovarian Carcinoma Cell Line OVAR79
Shnaider PV, Malyants IK, Ivanova OM, Gordeeva VS, Svirina EA, Zakharzhevskaya NB, Shagaleeva OY, Selezneva OV, Bogomazova AN, Lukina MM, Aleshikova OI, Babaeva NA, Slonov AV, Shender VO |
International Journal of Molecular Sciences | 2024 |
|
Potential of phosphatase and tensin gene polymorphisms as salivary biomarkers in oral squamous cell carcinoma – A cross-sectional study
Narang BR, Deshmukh RS, Palaskar SJ, Bartake A, Patil S, Nitin P |
Journal of Oral and Maxillofacial Pathology : JOMFP | 2024 |
|
Comparative Protein Structural Network Analysis Reveals C-Terminal Tail Phosphorylation Structural Communication Fingerprint in PTEN-Associated Mutations in Autism and Cancer
Smith IN, Dawson JE, Eng C |
The journal of physical chemistry. B | 2023 |
|
Genetics and genomics in healthcare: The future is now.
Yehia L, Eng C |
Singapore Medical Journal | 2023 |
|
Characteristics of PTEN Mutation in Thyroid Tumours: A Retrospective Chart Review.
Bandargal S, Rajab M, Forest VI, Pusztaszeri MP, Hier MP, da Silva SD, Payne RJ |
Cancers | 2023 |
|
Autism-specific PTEN p.Ile135Leu variant and an autism genetic background combine to dysregulate cortical neurogenesis
Fu S, Bury LA, Eum J, Wynshaw-Boris A |
The American Journal of Human Genetics | 2023 |
|
Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications
Moghaddam M, Vivarelli S, Falzone L, Libra M, Bonavida B |
2023 | |
|
Hyperphosphorylated PTEN exerts oncogenic properties.
van Ree JH, Jeganathan KB, Fierro Velasco RO, Zhang C, Can I, Hamada M, Li H, Baker DJ, van Deursen JM |
Nature Communications | 2023 |
|
Pathogenesis of cancers derived from thyroid follicular cells.
Fagin JA, Krishnamoorthy GP, Landa I |
Nature reviews. Cancer | 2023 |
|
A young female of Cowden syndrome presenting with Lhermitte-Duclos disease: An illustrative case
Al-Noman A, Mokbul MI, Hossain N, Rana MS, Hasan MM, Islam MS |
Surgical neurology international | 2023 |
|
Integrative PTEN Enhancer Discovery Reveals a New Model of Enhancer Organization
Cerda-Smith CG, Hutchinson HM, Liu A, Goel VY, Sept C, Kim H, Casaní-Galdón S, Burkman KG, Bassil CF, Hansen AS, Aryee MJ, Johnstone SE, Eyler CE, Wood KC |
2023 | |
|
The First Familiar Case of PTEN-Related Disorder Reported in Albania
Bali D, Tabaku M, Gjikopulli A, Velmishi V, Tocilla B, Godo A, Cullufi P |
2023 | |
|
Differential cell cycle checkpoint evasion by PTEN germline mutations associated with dichotomous phenotypes of cancer versus autism spectrum disorder.
Hitomi M, Venegas J, Kang SC, Eng C |
Oncogene | 2023 |
|
Genomic diversity in functionally relevant genes modifies neurodevelopmental versus neoplastic risks in individuals with germline PTEN variants
Eng C, Kim A, Yehia L |
Research square | 2023 |
|
A Bi-Institutional Study of Gastrointestinal and Hepatic Manifestations in Children With PTEN Hamartoma Tumor Syndrome.
Liu D, MacFarland SP, Yehia L, Duvall MM, Mamula P, Kurowski JA, Greene CS, Radhakrishnan K, Eng C |
2023 | |
|
Challenges in Treating Genodermatoses: New Therapies at the Horizon
M Morren, E Legius, F Giuliano, S Hadj-Rabia, D Hohl, C Bodemer |
Frontiers in pharmacology | 2022 |
|
How can same-gene mutations promote both cancer and developmental disorders?
R Nussinov, C Tsai, H Jang |
Science Advances | 2022 |
|
Rare Hereditary Gynecological Cancer Syndromes
T Watanabe, S Soeda, Y Endo, C Okabe, T Sato, N Kamo, M Ueda, M Kojima, S Furukawa, H Nishigori, T Takahashi, K Fujimori |
International journal of molecular sciences | 2022 |
|
Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes
V Nosé, A Gill, J Teijeiro, A Perren, L Erickson |
Endocrine Pathology | 2022 |
|
Distinct metabolic profiles associated with autism spectrum disorder versus cancer in individuals with germline PTEN mutations
L Yehia, Y Ni, T Sadler, T Frazier, C Eng |
npj Genomic Medicine | 2022 |
|
Shape shifting: The multiple conformational substates of the PTEN N‐terminal PIP 2 ‐binding domain
J Dawson, I Smith, W Martin, K Khan, F Cheng, C Eng |
Protein science : a publication of the Protein Society | 2022 |
|
Current status and progress in immunotherapy for malignant pleural mesothelioma
Sun B, Dong Y, Xu J, Wang Z |
Chronic Diseases and Translational Medicine | 2022 |
|
Neurodevelopmental disorders, immunity, and cancer are connected.
Nussinov R, Tsai CJ, Jang H |
iScience | 2022 |
|
Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study.
Morgan FC, Yehia L, McDonald C, Martinez-Agosto JA, Hardan AY, Tamburro J, Sahin M, Bayart C, Eng C |
Journal of the American Academy of Dermatology | 2022 |
|
Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.
Brewer T, Yehia L, Bazeley P, Eng C |
The American Journal of Human Genetics | 2022 |
|
The role of PTEN in puromycin aminonucleoside-induced podocyte injury
Ren Q, Yu S, Zeng H, Xia H |
International journal of medical sciences | 2022 |
|
A progressive and refractory case of breast cancer with Cowden syndrome
Sueta A, Takeno M, Goto-Yamaguchi L, Tomiguchi M, Inao T, Yamamoto-Ibusuki M, Yamamoto Y |
World journal of surgical oncology | 2022 |
|
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss.
Mejía-Hernández JO, Keam SP, Saleh R, Muntz F, Fox SB, Byrne D, Kogan A, Pang L, Huynh J, Litchfield C, Caramia F, Lozano G, He H, You JM, Sandhu S, Williams SG, Haupt Y, Haupt S |
Cell Death and Disease | 2022 |
|
Structural and Dynamic Effects of PTEN C-Terminal Tail Phosphorylation.
Smith IN, Dawson JE, Krieger J, Thacker S, Bahar I, Eng C |
Journal of Chemical Information and Modeling | 2022 |
|
A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome.
Srivastava S, Jo B, Zhang B, Frazier T, Gallagher AS, Peck F, Levin AR, Mondal S, Li Z, Filip-Dhima R, Geisel G, Dies KA, Diplock A, Eng C, Hanna R, Sahin M, Hardan A |
Human Molecular Genetics | 2022 |
|
PTEN in Immunity.
Papa A, Pandolfi PP |
Current topics in microbiology and immunology | 2022 |
|
CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K-Akt pathway and epithelial-mesenchymal transition.
Shu C, Wang S, Hu J, Xu M, Deng H, Maimaiti Y, Huang T |
Journal of Endocrinological Investigation | 2022 |
|
The role of phosphoinositide 3-kinases in immune-inflammatory responses: potential therapeutic targets for abdominal aortic aneurysm
Zhou H, Wang L, Liu S, Wang W |
Cell cycle (Georgetown, Tex.) | 2022 |
|
BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways
Leu JD, Lin ST, Chen CT, Chang CA, Lee YJ |
International journal of molecular sciences | 2022 |
|
Mitochondria inter-organelle relationships in cancer protein aggregation
Genovese I, Fornetti E, Ruocco G |
Frontiers in Cell and Developmental Biology | 2022 |
|
Long‐term treatment of cancer‐prone germline PTEN mutant mice with low‐dose rapamycin extends lifespan and delays tumour development
Tibarewal P, Rathbone V, Constantinou G, Pearce W, Adil M, Varyova Z, Folkes L, Hampson A, Classen GA, Alves A, Carvalho S, Scudamore CL, Vanhaesebroeck B |
The Journal of Pathology | 2022 |
|
A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutations
Rodón J, Funchain P, Laetsch TW, Arkenau HT, Hervieu A, Singer CF, Murciano-Goroff YR, Chawla SP, Anthony K, Yamamiya I, Liu M, Halim AB, Benhadji KA, Takahashi O, Delaloge S |
Future Oncology | 2022 |
|
WWP1 inactivation enhances efficacy of PI3K inhibitors while suppressing their toxicities in breast cancer models
Takahiro Kishikawa, Hiroshi Higuchi, Limei Wang, Nivedita Panch, Valerie Maymi, Sachem Best, Samuel Lee, Genso Notoya, Alex Toker, Lydia E Matesic, Gerburg M. Wulf, Wenyi Wei, Motoyuki Otsuka, Kazuhiko Koike, John G. Clohessy, Yu-Ru Lee, Pier Paolo Pandolfi |
Journal of Clinical Investigation | 2021 |
|
ENT2 facilitates brain endothelial cell penetration and blood-brain barrier transport by a tumor-targeting anti-DNA autoantibody
Zahra Rattray, Gang Deng, Shenqi Zhang, Anupama Shirali, Christopher K. May, Xiaoyong Chen, Benedette J. Cuffari, Jun Liu, Pan Zou, Nicholas Rattray, Caroline H Johnson, Valentina Dubljevic, James A. Campbell, Anita Huttner, Joachim M Baehring, Jiangbing Zhou, James E Hansen |
JCI Insight | 2021 |
|
Therapeutic Potential of Remote Ischemic Conditioning in Vascular Cognitive Impairment
R Xu, Q He, Y Wang, Y Yang, ZN Guo |
Frontiers in cellular neuroscience | 2021 |
|
The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma
JN Hubert, V Suybeng, M Vallée, TM Delhomme, E Maubec, A Boland, D Bacq, JF Deleuze, F Jouenne, P Brennan, JD McKay, MF Avril, BB Paillerets, E Chanudet |
Cancers | 2021 |
|
Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates
JM Cameselle-Teijeiro, O Mete, SL Asa, V LiVolsi |
Endocrine Pathology | 2021 |
|
Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism
TW Frazier, R Jaini, RM Busch, M Wolf, T Sadler, P Klaas, AY Hardan, JA Martinez-Agosto, M Sahin, C Eng, SK Warfield, B Scherrer, K Dies, R Filip-Dhima, A Gulsrud, E Hanson, JM Phillips |
Molecular autism | 2021 |
|
Germline nuclear-predominant Pten murine model exhibits impaired social and perseverative behavior, microglial activation, and increased oxytocinergic activity
N Sarn, S Thacker, H Lee, C Eng |
Molecular autism | 2021 |
|
A randomized double-blind controlled trial of everolimus in individuals with PTEN mutations: Study design and statistical considerations
AY Hardan, B Jo, TW Frazier, P Klaas, RM Busch, KA Dies, R Filip-Dhima, AV Snow, C Eng, R Hanna, B Zhang, M Sahin |
Contemporary Clinical Trials Communications | 2021 |
|
Understanding the Origins of Loss of Protein Function by Analyzing the Effects of Thousands of Variants on Activity and Abundance
M Cagiada, KE Johansson, A Valanciute, SV Nielsen, R Hartmann-Petersen, JJ Yang, DM Fowler, A Stein, K Lindorff-Larsen, B Ozkan |
Molecular Biology and Evolution | 2021 |
|
Non-canonical role of wild-type SEC23B in the cellular stress response pathway
L Yehia, D Liu, S Fu, P Iyer, C Eng |
Cell Death and Disease | 2021 |
|
Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL
M Olazábal-Morán, M Sánchez-Ortega, L Martínez-Muñoz, C Hernández, MS Rodríguez, M Mellado, AC Carrera |
Cells | 2021 |
|
Transcriptome-(phospho)proteome characterization of brain of a germline model of cytoplasmic-predominant Pten expression with autism-like phenotypes
S Thacker, C Eng |
npj Genomic Medicine | 2021 |
|
Multiple facial papules in a middle-aged man
R Mo, H Wang, Z Lin |
INDIAN J DERMATOL VE | 2021 |
|
The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane
H Jang, IN Smith, C Eng, R Nussinov |
iScience | 2021 |
|
PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis
G Innella, E Bonora, I Neri, A Virdi, A Guglielmo, LM Pradella, C Ceccarelli, LB Amato, A Lanzoni, S Miccoli, G Gasparre, R Zuntini, D Turchetti |
Frontiers in Medicine | 2021 |
|
L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation
B Castejón-Vega, A Rubio, AJ Pérez-Pulido, JL Quiles, JD Lane, B Fernández-Domínguez, MB Cachón-González, C Martín-Ruiz, A Sanz, TM Cox, E Alcocer-Gómez, MD Cordero |
Cells | 2021 |
|
A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation
P Ganguly, L Madonsela, JT Chao, CJ Loewen, TP OConnor, EM Verheyen, DW Allan, N Perrimon |
PLoS genetics | 2021 |
|
mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in patients with juvenile polyposis of infancy with PTEN-BMPR1A deletion
H Taylor, D Yerlioglu, C Phen, A Ballauff, N Nedelkopoulou, I Spier, I Loverdos, V Busoni, J Heise, P Dale, T de Meij, K Sweet, M Cohen, V Fox, E Mas, S Aretz, C Eng, S Buderus, M Thomson, I Rojas, H Uhlig |
Human Molecular Genetics | 2021 |
|
Posttranslational Regulation and Conformational Plasticity of PTEN
L Kotelevets, B Trifault, E Chastre, MG Scott |
Cold Spring Harbor Perspectives in Medicine | 2020 |
|
mTOR in Lung Neoplasms
I Krencz, A Sebestyen, A Khoor |
Pathology & Oncology Research | 2020 |
|
Emerging role of PTEN loss in evasion of the immune response to tumours
T Vidotto, CM Melo, E Castelli, M Koti, RB dos Reis, JA Squire |
British Journal of Cancer | 2020 |
|
WWP1 germline variants are associated with normocephalic autism spectrum disorder
G Novelli, A Novelli, P Borgiani, D Cocciadiferro, M Biancolella, E Agolini, M Pietrosanto, R Casalone, M Helmer-Citterich, E Giardina, SK Jain, W Wei, C Eng, PP Pandolfi |
Cell Death and Disease | 2020 |
|
WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition
YR Lee, L Yehia, T Kishikawa, Y Ni, B Leach, J Zhang, N Panch, J Liu, W Wei, C Eng, PP Pandolfi |
New England Journal of Medicine | 2020 |
|
Early-onset renal cell carcinoma in PTEN harmatoma tumour syndrome
RH Kim, X Wang, AJ Evans, SC Campbell, JK Nguyen, KM Farncombe, C Eng |
npj Genomic Medicine | 2020 |
|
Regulating tumor suppressor genes: post-translational modifications
L Chen, S Liu, Y Tao |
Signal Transduction and Targeted Therapy | 2020 |
|
PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?
L Yehia, C Eng |
Human Molecular Genetics | 2020 |
|
Autism‐associated PTEN missense mutation leads to enhanced nuclear localization and neurite outgrowth in an induced pluripotent stem cell line
CW Wong, Y Wang, T Liu, L Li, SK Cheung, PM Or, AS Cheng, KW Choy, JP Burbach, B Feng, RC Chang, AM Chan |
The FEBS journal | 2020 |
|
An Integrated Deep-Mutational-Scanning Approach Provides Clinical Insights on PTEN Genotype-Phenotype Relationships
TL Mighell, S Thacker, E Fombonne, C Eng, BJ ORoak |
The American Journal of Human Genetics | 2020 |
|
PTEN suppresses epithelial–mesenchymal transition and cancer stem cell activity by downregulating Abi1
Y Qi, J Liu, J Chao, MP Scheuerman, SA Rahimi, LY Lee, S Li |
Scientific Reports | 2020 |
|
Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes SP Hasson, T Menes, A Sonnenblick |
Pharmacogenomics and Personalized Medicine | 2020 |
|
Alternative splicing landscape of the neural transcriptome in a cytoplasmic-predominant Pten expression murine model of autism-like Behavior
S Thacker, M Sefyi, C Eng |
Translational Psychiatry | 2020 |
|
Pharmacogenomics for immunotherapy and immune-related cardiotoxicity
JA Castrillon, C Eng, F Cheng |
Human Molecular Genetics | 2020 |
|
Recent advances in PTEN signalling axes in cancer
JT Chow, L Salmena |
2020 | |
|
The Role of PTEN in Innate and Adaptive Immunity
H Taylor, AD Laurence, HH Uhlig |
Cold Spring Harbor Perspectives in Medicine | 2019 |
|
PTEN Mouse Models of Cancer Initiation and Progression
YR Lee, PP Pandolfi |
Cold Spring Harbor Perspectives in Medicine | 2019 |
|
Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis
MR Linton, JJ Moslehi, VR Babaev |
International journal of molecular sciences | 2019 |
|
PTEN in Hereditary and Sporadic Cancer
J Ngeow, C Eng |
Cold Spring Harbor Perspectives in Medicine | 2019 |
|
PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
C Bazzichetto, F Conciatori, M Pallocca, I Falcone, M Fanciulli, F Cognetti, M Milella, L Ciuffreda |
Cancers | 2019 |
|
PTEN in the Stroma
KA Thies, JE Lefler, G Leone, MC Ostrowski |
Cold Spring Harbor Perspectives in Medicine | 2019 |
|
Quantitative Measurement of Functional Activity of the PI3K Signaling Pathway in Cancer
A van de Stolpe |
Cancers | 2019 |
|
Largescale population genomics versus deep phenotyping: Brute force or elegant pragmatism towards precision medicine
L Yehia, C Eng |
npj Genomic Medicine | 2019 |
|
The PTEN–PI3K Axis in Cancer
Papa, Pandolfi |
Biomolecules | 2019 |
|
PTEN modulates gene transcription by redistributing genome-wide RNA polymerase II occupancy
A Abbas, R Padmanabhan, T Romigh, C Eng |
Human Molecular Genetics | 2019 |
|
Distinct Alterations in Tricarboxylic Acid Cycle Metabolites Associate with Cancer and Autism Phenotypes in Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome
L Yehia, Y Ni, F Feng, M Seyfi, T Sadler, TW Frazier, C Eng |
The American Journal of Human Genetics | 2019 |
|
Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives
L Carbognin, F Miglietta, I Paris, MV Dieci |
Cancers | 2019 |
|
Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN
JF Sun, D Zhang, CJ Gao, YW Zhang, QS Dai |
Medical Science Monitor Basic Research | 2019 |
|
Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function
T Fernández-Acero, E Bertalmio, S Luna, J Mingo, I Bravo-Plaza, I Rodríguez-Escudero, M Molina, R Pulido, VJ Cid |
Cells | 2019 |
|
The Impact of Genetic Variants on PTEN Molecular Functions and Cellular Phenotypes
N Hasle, KA Matreyek, DM Fowler |
Cold Spring Harbor Perspectives in Medicine | 2019 |
|
Autism Spectrum Disorder Associated with Germline Heterozygous PTEN Mutations
TW Frazier |
Cold Spring Harbor Perspectives in Medicine | 2019 |
|
Toward Systems Pathology for PTEN Diagnostics
N Haddadi, G Travis, N Nassif, A Simpson, D Marsh |
Cold Spring Harbor Perspectives in Medicine | 2019 |
|
PTEN interacts with RNA polymerase II to dephosphorylate polymerase II C-terminal domain.
Abbas A, Romigh T, Eng C |
Oncotarget | 2019 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)